Back
BlueLinx Holdings Vs. Dyne Therapeutics Industry Stock Comparison
Buy
57
BXC
BlueLinx Holdings
Last Price:
122.03
Seasonality Move:
13.66%
Sell
37
DYN
Dyne Therapeutics
Last Price:
28.46
Seasonality Move:
35.22%
Buy
57
BlueLinx Holdings (BXC)
is a Buy
Is BlueLinx Holdings a Buy, Sell or Hold?
- The current BlueLinx Holdings [BXC] share price is $122.26. The Score for BXC is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- BXC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
Dyne Therapeutics (DYN)
is a Sell
Is Dyne Therapeutics a Buy, Sell or Hold?
- The current Dyne Therapeutics [DYN] share price is $28.48. The Score for DYN is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- DYN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BXC Stock Price Chart
What is BlueLinx Holdings's stock price today?
-
The BlueLinx Holdings share price today is $122.26
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BXC is experiencing slight selling pressure.
DYN Stock Price Chart
What is Dyne Therapeutics's stock price today?
-
The Dyne Therapeutics share price today is $28.48
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing selling pressure, which indicates risk of future bearish movement.
BXC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.96 | Buy |
| Relative Strength Index (14 RSI): | 67.86 | Buy |
| Chaikin Money Flow: | -14847 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (103.55 - 115.43) | Buy |
| Bollinger Bands (100): | (94.39 - 112.41) | Buy |
DYN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.55 | Sell |
| Relative Strength Index (14 RSI): | 34.22 | Sell |
| Chaikin Money Flow: | -639318 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.38 - 33.58) | Sell |
| Bollinger Bands (100): | (31.67 - 42.59) | Sell |
BXC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 115.76 | Buy |
| 20-day SMA: | 110.05 | Buy |
| 50-day SMA: | 105.46 | Buy |
| 200-day SMA: | 108.37 | Buy |
| 8-day EMA: | 116.65 | Buy |
| 20-day EMA: | 111.69 | Buy |
| 50-day EMA: | 107.52 | Buy |
| 200-day EMA: | 103.94 | Buy |
DYN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.97 | Sell |
| 20-day SMA: | 31.25 | Sell |
| 50-day SMA: | 33.25 | Sell |
| 200-day SMA: | 31.9 | Sell |
| 8-day EMA: | 29.33 | Sell |
| 20-day EMA: | 30.73 | Sell |
| 50-day EMA: | 33.25 | Sell |
| 200-day EMA: | 30.83 | Sell |
BlueLinx Holdings Earnings Growth & BXC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.76 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.89 per share, and a decrease next year of $0.01 per share.
Dyne Therapeutics Earnings Growth & DYN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.78 per share, and a decrease next year of $0.05 per share.
BlueLinx Holdings Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Dyne Therapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||